Search Browse Earnings

Polomar Health Services, Inc.

OTC:PMHS

Pharmaceutical Preparations·PALM HARBOR, FL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Refer Rasmus

Revenue

$41,844

+21.2% YoY

FY 2024

Adj. EBITDA

-$434,999

-1039.6% margin

FY 2024

Net Income

-$587,997

-1405.2% margin

FY 2024

EPS (Diluted)

-$0.02

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$6,191

FY 2024

Total Debt

—

Net Cash

$6,191

FY 2024

Enterprise Value

—

Debt / EBITDA

0.0x

FY 2024

EV / EBITDA

—

Employees

—